Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
27.0%
% of XLV's 64 holdings also in AGNG
18.9%
% of AGNG's 90 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus AGNG)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in AGNG |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.8% | 6.2% | 6.2% |
|
ABBVIE INC | 5.6% | 3.1% | 3.1% |
|
JOHNSON & JOHNSON | 6.9% | 2.7% | 2.7% |
|
AMGEN INC | 2.7% | 3.2% | 2.7% |
|
STRYKER CORP | 2.2% | 3.6% | 2.2% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to AGNG
|
UNITEDHEALTH GROUP INC | 7.9% |
|
MERCK & CO. INC. | 6.1% |
|
ELI LILLY & CO | 5.5% |
|
THERMO FISHER SCIENTIFIC INC | 4.2% |
|
JOHNSON & JOHNSON | 4.2% |
|
ABBOTT LABORATORIES | 3.6% |
|
DANAHER CORP | 3.0% |
|
PFIZER INC | 2.8% |
|
INTUITIVE SURGICAL INC | 2.6% |
|
ABBVIE INC | 2.5% |
XLV Underweight Relative to AGNG
 |
NOVO NORDISK A/S-B | -4.5% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.3% |
|
WELLTOWER, INC. | -3.7% |
 |
ALCON, INC. | -3.5% |
 |
ASTRAZENECA PLC-SPONS ADR | -2.7% |
|
DEXCOM INC | -2.5% |
|
EDWARDS LIFESCIENCES CORP | -2.2% |
|
BOSTON SCIENTIFIC CORP | -2.1% |
|
ROCHE HOLDING AG-BR | -1.9% |
|
TERUMO CORP | -1.8% |